Key result
Historical review tracks the evolution of anticoagulation and vena caval interruption for venous thromboembolism.
Answers are grounded in this paper and cite their sources.
In 1960, Barritt and Jordan performed the first randomized trial demonstrating the efficacy of anticoagulant therapy in the treatment of venous thromboembolism. Since then, important therapeutic advances have been made in the treatment of deep venous thrombosis and pulmonary embolism. This paper reviews the important clinical trials involving anticoagulant therapy and vena caval interruption. The studies are discussed from a historical perspective, and an attempt is made to analyze both the thought processes that prompted their design and the reasons why they changed practice.
No takes yet. Share an insight, caveat, or question.
Hirsh et al. (2001) conducted a review in Venous thromboembolism (deep venous thrombosis and pulmonary embolism). Anticoagulant therapy and vena caval interruption was evaluated. Anticoagulant therapy and vena caval interruption trials since 1960 are reviewed from a historical perspective regarding the treatment of venous thromboembolism.
Synapse has enriched 10 related papers. Consider them for comparative context: